NVS
Novartis AG
NYSE · Healthcare · Drug Manufacturers - General · CH
$159.68
−2.09%Margins
Gross margin
74.4%
EBITDA margin
40.0%
EBIT margin
30.5%
Net margin
22.9%
FCF margin
28.4%
30.7%
Return on equity
10.5%
Return on assets
18.8%
Return on invested capital
0.46x
Asset turnover
$18.4B
Cash from operations
$4.05
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026